Research sites need to be especially cautious about signatures when they work with children or other populations that are unable to provide informed consent and must have a guardian or legal representative sign the IC form, an expert advises.
Sponsors, clinical research organizations (CROs), and others increasingly are collecting site-level metrics, along with other data pertaining to clinical research performance. If clinical trial sites are not finding out what their metrics show, then they're missing a good opportunity to improve their operations.
Physicians at the University of California-San Diego (UCSD) report a cluster of 5 cases of cutaneous Leishmaniasis in illegal immigrants from East Africa, which surprisingly turned out to be consistent with New World Leishmaniasis, although all 5 had come from an area endemic for Old World Leishmaniasis. How did this occur?
